134 related articles for article (PubMed ID: 25588739)
1. Evaluation of in vivo antitumor effects of ANT2 shRNA delivered using PEI and ultrasound with microbubbles.
Park DH; Jung BK; Lee YS; Jang JY; Kim MK; Lee JK; Park H; Seo J; Kim CW
Gene Ther; 2015 Apr; 22(4):325-32. PubMed ID: 25588739
[TBL] [Abstract][Full Text] [Related]
2. Combined RNA interference of adenine nucleotide translocase-2 and ganciclovir therapy in hepatocellular carcinoma.
Kim JE; Hwang MH; Lee HW; Lee SW; Lee J; Ahn BC
Nucl Med Biol; 2013 Nov; 40(8):987-93. PubMed ID: 24054501
[TBL] [Abstract][Full Text] [Related]
3. Suppression of adenine nucleotide translocase-2 by vector-based siRNA in human breast cancer cells induces apoptosis and inhibits tumor growth in vitro and in vivo.
Jang JY; Choi Y; Jeon YK; Kim CW
Breast Cancer Res; 2008; 10(1):R11. PubMed ID: 18267033
[TBL] [Abstract][Full Text] [Related]
4. ANT2 shRNA downregulates miR-19a and miR-96 through the PI3K/Akt pathway and suppresses tumor growth in hepatocellular carcinoma cells.
Baik SH; Lee J; Lee YS; Jang JY; Kim CW
Exp Mol Med; 2016 Mar; 48(3):e222. PubMed ID: 27012708
[TBL] [Abstract][Full Text] [Related]
5. Targeted gene delivery in tumor xenografts by the combination of ultrasound-targeted microbubble destruction and polyethylenimine to inhibit survivin gene expression and induce apoptosis.
Chen ZY; Liang K; Qiu RX
J Exp Clin Cancer Res; 2010 Nov; 29(1):152. PubMed ID: 21092274
[TBL] [Abstract][Full Text] [Related]
6. The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131.
Choi Y; Lee HW; Lee J; Jeon YH
BMC Cancer; 2013 Mar; 13():143. PubMed ID: 23522027
[TBL] [Abstract][Full Text] [Related]
7. ANT2 suppression by shRNA may be able to exert anticancer effects in HCC further by restoring SOCS1 expression.
Jang JY; Jeon YK; Lee CE; Kim CW
Int J Oncol; 2013 Feb; 42(2):574-82. PubMed ID: 23242177
[TBL] [Abstract][Full Text] [Related]
8. Chemosensitization by knockdown of adenine nucleotide translocase-2.
Le Bras M; Borgne-Sanchez A; Touat Z; El Dein OS; Deniaud A; Maillier E; Lecellier G; Rebouillat D; Lemaire C; Kroemer G; Jacotot E; Brenner C
Cancer Res; 2006 Sep; 66(18):9143-52. PubMed ID: 16982757
[TBL] [Abstract][Full Text] [Related]
9. Recombinant adeno-associated virus-, polyethylenimine/plasmid- and lipofectamine/carboxyfluorescein-labeled small interfering RNA-based transfection in retinal pigment epithelial cells with ultrasound and/or SonoVue.
Li H; Wan C; Li F
Mol Med Rep; 2015 May; 11(5):3609-14. PubMed ID: 25607376
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound-targeted microbubble destruction (UTMD) assisted delivery of shRNA against PHD2 into H9C2 cells.
Zhang L; Sun Z; Ren P; Lee RJ; Xiang G; Lv Q; Han W; Wang J; Ge S; Xie M
PLoS One; 2015; 10(8):e0134629. PubMed ID: 26267649
[TBL] [Abstract][Full Text] [Related]
11. Enhanced shRNA delivery by the combination of polyethylenimine, ultrasound, and nanobubbles in liver cancer.
Li H; Wang Z; Zhang J; Yuan C; Zhang H; Hou X; Zhang D
Technol Health Care; 2019; 27(S1):263-272. PubMed ID: 31045545
[TBL] [Abstract][Full Text] [Related]
12. The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway.
Jiang HL; Xu CX; Kim YK; Arote R; Jere D; Lim HT; Cho MH; Cho CS
Biomaterials; 2009 Oct; 30(29):5844-52. PubMed ID: 19640582
[TBL] [Abstract][Full Text] [Related]
13. Electrophoretic purification of tumor-targeted polyethylenimine-based polyplexes reduces toxic side effects in vivo.
Fahrmeir J; Gunther M; Tietze N; Wagner E; Ogris M
J Control Release; 2007 Oct; 122(3):236-45. PubMed ID: 17692422
[TBL] [Abstract][Full Text] [Related]
14. A hybrid CMV-H1 construct improves efficiency of PEI-delivered shRNA in the mouse brain.
Hassani Z; François JC; Alfama G; Dubois GM; Paris M; Giovannangeli C; Demeneix BA
Nucleic Acids Res; 2007; 35(9):e65. PubMed ID: 17426128
[TBL] [Abstract][Full Text] [Related]
15. The hepatoprotective effects of adenine nucleotide translocator-2 against aging and oxidative stress.
Kim HS; Je JH; Son TG; Park HR; Ji ST; Pokharel YR; Jeon HM; Kang KW; Kang HS; Chang SC; Kim HS; Chung HY; Lee J
Free Radic Res; 2012 Jan; 46(1):21-9. PubMed ID: 22034909
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of local injection of lentivirus-delivered stathmin1 and stathmin1 shRNA in human gastric cancer xenograft mouse.
Akhtar J; Wang Z; Yu C; Zhang ZP
J Gastroenterol Hepatol; 2014 Sep; 29(9):1685-91. PubMed ID: 24720379
[TBL] [Abstract][Full Text] [Related]
17. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
[TBL] [Abstract][Full Text] [Related]
18. Induced apoptosis with ultrasound-mediated microbubble destruction and shRNA targeting survivin in transplanted tumors.
Chen ZY; Liang K; Xie MX; Wang XF; Lü Q; Zhang J
Adv Ther; 2009 Jan; 26(1):99-106. PubMed ID: 19083158
[TBL] [Abstract][Full Text] [Related]
19. Low-molecular weight chitosan/vascular endothelial growth factor short hairpin RNA for the treatment of hepatocellular carcinoma.
Huang Z; Dong L; Chen J; Gao F; Zhang Z; Chen J; Zhang J
Life Sci; 2012 Dec; 91(23-24):1207-15. PubMed ID: 23044224
[TBL] [Abstract][Full Text] [Related]
20. Receptor-mediated gene delivery using polyethylenimine (PEI) coupled with polypeptides targeting FGF receptors on cells surface.
Li D; Wang QQ; Tang GP; Huang HL; Shen FP; Li JZ; Yu H
J Zhejiang Univ Sci B; 2006 Nov; 7(11):906-11. PubMed ID: 17048306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
